Tags

Type your tag names separated by a space and hit enter

The safety of oral contraceptives: epidemiologic insights from the first 30 years.
Am J Obstet Gynecol. 1992 Jun; 166(6 Pt 2):1950-4.AJ

Abstract

Because oral contraceptives are used by tens of millions of healthy women, their safety for short-term and long-term use is an important issue that has been examined in a large number of epidemiologic studies. These studies have become more rigorous and have increased in size and analytic sophistication over the years. Although breast cancer remains the most important safety concern, the bulk of recent data suggests that oral contraceptives have no overall impact on a woman's risk of developing this disease. The results are less clear on the risk of cervical cancer and its precursors because of methodologic problems. However, the newer oral contraceptive formulations no longer appear to be associated with an increased risk of myocardial infarction or stroke.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

1605284

Citation

Grimes, D A.. "The Safety of Oral Contraceptives: Epidemiologic Insights From the First 30 Years." American Journal of Obstetrics and Gynecology, vol. 166, no. 6 Pt 2, 1992, pp. 1950-4.
Grimes DA. The safety of oral contraceptives: epidemiologic insights from the first 30 years. Am J Obstet Gynecol. 1992;166(6 Pt 2):1950-4.
Grimes, D. A. (1992). The safety of oral contraceptives: epidemiologic insights from the first 30 years. American Journal of Obstetrics and Gynecology, 166(6 Pt 2), 1950-4.
Grimes DA. The Safety of Oral Contraceptives: Epidemiologic Insights From the First 30 Years. Am J Obstet Gynecol. 1992;166(6 Pt 2):1950-4. PubMed PMID: 1605284.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The safety of oral contraceptives: epidemiologic insights from the first 30 years. A1 - Grimes,D A, PY - 1992/6/1/pubmed PY - 1992/6/1/medline PY - 1992/6/1/entrez KW - Americas KW - Behavior KW - Biology KW - Breast Cancer KW - Cancer KW - Cardiovascular Effects KW - Cervical Cancer KW - Contraception KW - Contraceptive Methods--beneficial effects KW - Contraceptive Methods--side effects KW - Developed Countries KW - Developing Countries KW - Diseases KW - Dysmenorrhea KW - Epidemiologic Methods KW - Europe KW - Evaluation KW - Family Planning KW - Hemic System KW - Hemoglobin Level KW - Infections KW - Infertility KW - Literature Review KW - Liver Neoplasms KW - Menstruation Disorders KW - Neoplasms KW - Neoplasms, Benign KW - North America KW - Northern America KW - Northern Europe KW - Oral Contraceptives--beneficial effects KW - Oral Contraceptives--side effects KW - Ovarian Cancer KW - Ovarian Cysts KW - Pelvic Infections KW - Physiology KW - Pregnancy Complications KW - Pregnancy, Ectopic KW - Reproduction KW - Research Methodology KW - Risk Assessment KW - Smoking KW - United Kingdom KW - United States SP - 1950 EP - 4 JF - American journal of obstetrics and gynecology JO - Am. J. Obstet. Gynecol. VL - 166 IS - 6 Pt 2 N2 - Because oral contraceptives are used by tens of millions of healthy women, their safety for short-term and long-term use is an important issue that has been examined in a large number of epidemiologic studies. These studies have become more rigorous and have increased in size and analytic sophistication over the years. Although breast cancer remains the most important safety concern, the bulk of recent data suggests that oral contraceptives have no overall impact on a woman's risk of developing this disease. The results are less clear on the risk of cervical cancer and its precursors because of methodologic problems. However, the newer oral contraceptive formulations no longer appear to be associated with an increased risk of myocardial infarction or stroke. SN - 0002-9378 UR - https://www.unboundmedicine.com/medline/citation/1605284/The_safety_of_oral_contraceptives:_epidemiologic_insights_from_the_first_30_years_ L2 - https://linkinghub.elsevier.com/retrieve/pii/0002-9378(92)91394-P DB - PRIME DP - Unbound Medicine ER -